Loading...
CAUTION ADVISED USING COMBINATION KETOCONAZOLE AND PD-1 INHIBITORS
OBJECTIVE: Immune checkpoint inhibitors are approved to treat multiple cancers. We report life-threatening hepatic failure in 2 consecutive patients with Cushing syndrome that were treated with ketoconazole (KTZ) in combination with 2 different programmed cell death protein 1 (PD-1) inhibitors, Nivo...
Na minha lista:
| Udgivet i: | AACE Clin Case Rep |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Association of Clinical Endocrinologists
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7511096/ https://ncbi.nlm.nih.gov/pubmed/32984529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2020-0100 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|